275 related articles for article (PubMed ID: 11882359)
1. Leukemic B cells clonally identical to myeloma plasma cells are myelomagenic in NOD/SCID mice.
Pilarski LM; Seeberger K; Coupland RW; Eshpeter A; Keats JJ; Taylor BJ; Belch AR
Exp Hematol; 2002 Mar; 30(3):221-8. PubMed ID: 11882359
[TBL] [Abstract][Full Text] [Related]
2. A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single-cell and in situ reverse transcriptase-polymerase chain reaction.
Szczepek AJ; Seeberger K; Wizniak J; Mant MJ; Belch AR; Pilarski LM
Blood; 1998 Oct; 92(8):2844-55. PubMed ID: 9763569
[TBL] [Abstract][Full Text] [Related]
3. Clonotypic myeloma cells able to xenograft myeloma to nonobese diabetic severe combined immunodeficient mice copurify with CD34 (+) hematopoietic progenitors.
Pilarski LM; Belch AR
Clin Cancer Res; 2002 Oct; 8(10):3198-204. PubMed ID: 12374689
[TBL] [Abstract][Full Text] [Related]
4. CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells.
Kim D; Park CY; Medeiros BC; Weissman IL
Leukemia; 2012 Dec; 26(12):2530-7. PubMed ID: 22733078
[TBL] [Abstract][Full Text] [Related]
5. The blood B-cells and bone marrow plasma cells in patients with multiple myeloma share identical IgH rearrangements.
Bergsagel PL; Masellis Smith A; Belch AR; Pilarski LM
Curr Top Microbiol Immunol; 1995; 194():17-24. PubMed ID: 7534667
[TBL] [Abstract][Full Text] [Related]
6. Myeloma progenitors in the blood of patients with aggressive or minimal disease: engraftment and self-renewal of primary human myeloma in the bone marrow of NOD SCID mice.
Pilarski LM; Hipperson G; Seeberger K; Pruski E; Coupland RW; Belch AR
Blood; 2000 Feb; 95(3):1056-65. PubMed ID: 10648422
[TBL] [Abstract][Full Text] [Related]
7. The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell.
Billadeau D; Ahmann G; Greipp P; Van Ness B
J Exp Med; 1993 Sep; 178(3):1023-31. PubMed ID: 8350044
[TBL] [Abstract][Full Text] [Related]
8. Phenotyping studies of clonotypic B lymphocytes from patients with multiple myeloma by flow cytometry.
Conway EJ; Wen J; Feng Y; Mo A; Huang WT; Keever-Taylor CA; Hari P; Vesole DH; Chang CC
Arch Pathol Lab Med; 2009 Oct; 133(10):1594-9. PubMed ID: 19792049
[TBL] [Abstract][Full Text] [Related]
9. Persistent preswitch clonotypic myeloma cells correlate with decreased survival: evidence for isotype switching within the myeloma clone.
Reiman T; Seeberger K; Taylor BJ; Szczepek AJ; Hanson J; Mant MJ; Coupland RW; Belch AR; Pilarski LM
Blood; 2001 Nov; 98(9):2791-9. PubMed ID: 11675353
[TBL] [Abstract][Full Text] [Related]
10. In multiple myeloma, circulating hyperdiploid B cells have clonotypic immunoglobulin heavy chain rearrangements and may mediate spread of disease.
Pilarski LM; Giannakopoulos NV; Szczepek AJ; Masellis AM; Mant MJ; Belch AR
Clin Cancer Res; 2000 Feb; 6(2):585-96. PubMed ID: 10690543
[TBL] [Abstract][Full Text] [Related]
11. CD34+ cells in the blood of patients with multiple myeloma express CD19 and IgH mRNA and have patient-specific IgH VDJ gene rearrangements.
Szczepek AJ; Bergsagel PL; Axelsson L; Brown CB; Belch AR; Pilarski LM
Blood; 1997 Mar; 89(5):1824-33. PubMed ID: 9057669
[TBL] [Abstract][Full Text] [Related]
12. In multiple myeloma clonotypic CD38- /CD19+ / CD27+ memory B cells recirculate through bone marrow, peripheral blood and lymph nodes.
Rasmussen T; Lodahl M; Hancke S; Johnsen HE
Leuk Lymphoma; 2004 Jul; 45(7):1413-7. PubMed ID: 15359642
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
Kara IO; Sahin B; Paydas S; Cetiner S
Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
[TBL] [Abstract][Full Text] [Related]
14. CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients.
Hosen N; Matsuoka Y; Kishida S; Nakata J; Mizutani Y; Hasegawa K; Mugitani A; Ichihara H; Aoyama Y; Nishida S; Tsuboi A; Fujiki F; Tatsumi N; Nakajima H; Hino M; Kimura T; Yata K; Abe M; Oka Y; Oji Y; Kumanogoh A; Sugiyama H
Leukemia; 2012 Sep; 26(9):2135-41. PubMed ID: 22430638
[TBL] [Abstract][Full Text] [Related]
15. Characterization of clonogenic multiple myeloma cells.
Matsui W; Huff CA; Wang Q; Malehorn MT; Barber J; Tanhehco Y; Smith BD; Civin CI; Jones RJ
Blood; 2004 Mar; 103(6):2332-6. PubMed ID: 14630803
[TBL] [Abstract][Full Text] [Related]
16. The evaluation of minimal residual disease in multiple myeloma by fluorescent molecular beacons in real time PCR of IgH gene rearrangements and correlation with flow cytometry.
Kara IO; Duman BB; Afsar CU
J BUON; 2013; 18(2):442-7. PubMed ID: 23818359
[TBL] [Abstract][Full Text] [Related]
17. Chromosomal aberrations are shared by malignant plasma cells and a small fraction of circulating CD19+ cells in patients with myeloma and monoclonal gammopathy of undetermined significance.
Zojer N; Schuster-Kolbe J; Assmann I; Ackermann J; Strasser K; Hübl W; Drach J; Ludwig H
Br J Haematol; 2002 Jun; 117(4):852-9. PubMed ID: 12060120
[TBL] [Abstract][Full Text] [Related]
18. Drug resistance in multiple myeloma: novel therapeutic targets within the malignant clone.
Pilarski LM; Mant MJ; Belch AR
Leuk Lymphoma; 1999 Jan; 32(3-4):199-210. PubMed ID: 10037018
[TBL] [Abstract][Full Text] [Related]
19. Circulating clonal lymphocytes in myeloma determined by mRNA in situ hybridization.
Joshua DE; Brown RD; Luo XF; Gibson J
Blood; 1996 Aug; 88(3):1125. PubMed ID: 8704226
[No Abstract] [Full Text] [Related]
20. Normal and clonal B lineage cells can be distinguished by their differential expression of B cell antigens and adhesion molecules in peripheral blood from multiple myeloma (MM) patients--diagnostic and clinical implications.
Luque R; Brieva JA; Moreno A; Manzanal A; Escribano L; Villarrubia J; Velasco JL; López-Jiménez J; Cerveró C; Otero MJ; Martínez J; Bellas C; Roldán E
Clin Exp Immunol; 1998 Jun; 112(3):410-8. PubMed ID: 9649209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
